StockData
SkinHealth Systems Inc. logo

SkinHealth Systems Inc. (SKIN) stock

SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30316% above fair value
$12.46−1.41 (-10.20%)

Close on Nov 18, 2026Market cap $1.62BP/E –Yield –

SkinHealth Systems operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

SkinHealth Systems's operating cash flow for the twelve months ending Jun 30, 2026 was $21.96M, down 44.3% year over year. For fiscal 2025 it was $37.49M, up 132.3% from the year before. The highest annual figure on record is $37.49M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$37.49M+132.3%
FY2024Dec 31, 2024$16.13M-25.8%
FY2023Dec 31, 2023$21.75M–
FY2022Dec 31, 2022-$106.60M–
FY2021Dec 31, 2021-$28.36M–
FY2020Dec 31, 2020-$12.44M-819.7%
FY2019Dec 31, 2019$1.73M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.67M-72.3%
Q1 FY2026Mar 31, 2026-$5.55M-285.4%
Q4 FY2025Dec 31, 2025$15.20M-7.7%
Q3 FY2025Sep 30, 2025$9.65M-6.5%
Q2 FY2025Jun 30, 2025$9.65M+55.6%
Q1 FY2025Mar 31, 2025$3.00M–
Q4 FY2024Dec 31, 2024$16.47M–
Q3 FY2024Sep 30, 2024$10.32M-42.6%
Q2 FY2024Jun 30, 2024$6.20M-71.8%
Q1 FY2024Mar 31, 2024-$16.85M–
Q4 FY2023Dec 31, 2023-$5.17M–
Q3 FY2023Sep 30, 2023$17.96M–
Q2 FY2023Jun 30, 2023$21.97M–
Q1 FY2023Mar 31, 2023-$13.01M–
Q4 FY2022Dec 31, 2022-$5.39M-264.5%
Q3 FY2022Sep 30, 2022-$31.40M-10637.2%
Q2 FY2022Jun 30, 2022-$31.34M–
Q1 FY2022Mar 31, 2022-$38.47M-3150.8%
Q4 FY2021Dec 31, 2021$3.28M–
Q3 FY2021Sep 30, 2021$298.00K–
Q2 FY2021Jun 30, 2021-$33.20M–
Q1 FY2021Mar 31, 2021$1.26M–
Q4 FY2020Dec 31, 2020-$411.00K–
Q3 FY2020Sep 30, 2020-$540–

More SkinHealth Systems figures

See a number that looks wrong?